1st Annual Intellectual Property Rights in the Biotech Industry
Developing a Patent Enforcement strategy to extend the patent life cycle of your innovations.
In the Chair:
Hear from your eminent Speaker Panel:
Dr. Diane Wilcock
Bo Hammer Jensen
Jens V. Nørgaard
This is a follow up event based on the success at our Intellectual Property Rights in the Biotech Industry conference held in June last year. This year’s conference will take IPR one step further from freedom-to-operate to find the best ways to protect your company’s most valuable assets, patents, through efficient patent enforcement strategies.
A patent has a limited life cycle of 20 years from the date of application. By adding new products your company is able to optimise protection throughout the entire patent life cycle and extend the life cycle to avoid generic competition.
Life sciences are a dynamic industry driven by innovation to cure human’s health. Both big pharmaceuticals and small biotech companies need to have a patent enforcement strategy to improve the original innovation in order to stay ahead of your competitors.
A strong IPR strategy that combines both pro-active patent enforcement and patent life cycle management strategies ensures your company further growth and inventions in a highly competitive business environment, the Life Sciences industry.
This international one day-conference will examine the role of patent enforcement to successfully design strategies that protects and extends the life of your biotechnological innovations. A speaker panel with world-leading biopharmaceuticals will provide your company with a platform to strengthen the role of IPR in order to maximise the protection of your company’s patents in the 21st century.
This conference will tackle key issues such as:
Target audience and Job Titles:
Presidents, Chief Executive Officers, Chief IP Counsel, Vice Presidents, Directors, Heads and Managers of:
Official Hotel & Airline: